Disease-modifying therapies for Alzheimer’s disease are under development based on the outcomes of molecular pathological studies that have progressed over the last 25 years. The current status of basic research on Alzheimer’s disease, its translation into clinical applications, and associated problems, will be discussed.
Molecular Pathology and Disease-modifying Therapy of Alzheimer Disease
Department of Neuropathology, School of Medicine, University of Tokyo
Psychiatria et Neurologia Japonica
113: 568-573, 2011
